Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.smhs.2020.09.002 http://scihub22266oqcxt.onion/10.1016/j.smhs.2020.09.002 34189485!7506347!34189485     free     free     free       Sports+Med+Health+Sci 2020 ; 2 (3): 172-173 Nephropedia Template TP {{tp|p=34189485|t=2020. Myocarditis in athletes after COVID-19 infection: The heart is not the only place to screen |pdf=|usr=}}{{34189485}} gab.com Text Myocarditis in athletes after COVID-19 infection: The heart is not the only place to screen JO: Sports Med Health Sci http://www.kidney.de/pget.php?&tw=1&pmid=34189485 #FOAvip COVID-19 patients are susceptible to hypercoagulability. For the safe return to sports after COVID-19, athletes or individuals wanting to resume physical activity should complete screening for myocardial injury and myocarditis. In addition, patients with COVID-19 are reported at prevalence of 27%-31% for venous thromboembolic events. The probability of deep vein thrombosis and pulmonary embolism prior to intensive exercise after COVID-19 infection should be considered. The prevalence of cardiac injury is reported at 19%, and the prevalence of deep vein thrombosis and pulmonary embolism is higher than that for myocarditis. Thus, the heart is not the only system needing screened. Examination for myocardial injury and myocarditis are mandatory. Also, deep vein thrombosis, and pulmonary thromboembolism must be considered, and when possible, blood troponin values, D-dimer prothrombin time, and activated partial thromboplastin time levels are determined for COVID-19 infection athletes or any individual before returning to sporting practice or intense physical activity or exercise. Twit Text FOAVip Myocarditis in athletes after COVID-19 infection: The heart is not the only place to screen ????Sports Med Health Sci http://www.kidney.de/pget.php?&tw=1&pmid=34189485 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34189485 #FOAvip English Wikipedia <ref>{{Cite pmid|34189485}}</ref> Myocarditis in athletes after COVID-19 infection: The heart is not the only place to screen #MMPMID34189485 Ibarrola M; Davolos I Sports Med Health Sci 2020[Sep]; 2 (3): 172-173 PMID34189485show ga COVID-19 patients are susceptible to hypercoagulability. For the safe return to sports after COVID-19, athletes or individuals wanting to resume physical activity should complete screening for myocardial injury and myocarditis. In addition, patients with COVID-19 are reported at prevalence of 27%-31% for venous thromboembolic events. The probability of deep vein thrombosis and pulmonary embolism prior to intensive exercise after COVID-19 infection should be considered. The prevalence of cardiac injury is reported at 19%, and the prevalence of deep vein thrombosis and pulmonary embolism is higher than that for myocarditis. Thus, the heart is not the only system needing screened. Examination for myocardial injury and myocarditis are mandatory. Also, deep vein thrombosis, and pulmonary thromboembolism must be considered, and when possible, blood troponin values, D-dimer prothrombin time, and activated partial thromboplastin time levels are determined for COVID-19 infection athletes or any individual before returning to sporting practice or intense physical activity or exercise. ?Myocarditis in athletes after COVID-19 infection: The heart is not the(epmc).pdf DeepDyve Pubget Overpricing